Clinical Trials Logo

Pregnant Women Undergoing TOP clinical trials

View clinical trials related to Pregnant Women Undergoing TOP.

Filter by:
  • None
  • Page 1

NCT ID: NCT04732260 Completed - Clinical trials for TOP - Failed Attempted Termination of Pregnancy

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - STEP 1 (CYMEVAL3-STEP1)

CYMEVAL3-STEP1
Start date: June 11, 2021
Phase: N/A
Study type: Interventional

In the model of the perfused cotyledon, Letermovir crosses the placenta to reach appropriate fetal concentration. The cotyledon model can only be performed in the third trimester placenta. Although it is probable that the transplacental passage in the second trimester is in the same range than the one found in the 2th trimester, it needs to be confirmed. The study will be divided in 2 steps: step 1 will study the Letermovir transplacental transfer in the second trimester and step 2 will test the efficacy of letermovir to inhibit replication in infected fetuses. Main objective To measure the Letermovir transplacental transfer in the second trimester and its accumulation in the amniotic fluid and the placenta in the second trimester Primary end point: Concentrations reached in fetal blood relative to EC50 of letermovir.